Cobimetinib racemate prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
Molecular Weight
531.31
Molecular Formula
C21H21F3IN3O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Cobimetinib racemate can be used to investigate the inhibition of MEK1/2 for oncology research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.